Introduction

In 2026 a new format is appearing on familiar shelves: CBD chewing gum. What began as a niche innovation in boutique wellness shops has moved quickly into mainstream retail conversations, with multiple supermarket chains and high‑street retailers trialling CBD gum as a convenient, single‑serve wellness SKU. This piece examines what is trending, why it matters to retailers and shoppers, examples from adjacent CBD formats, and what the near future may hold for this rising category.

What's trending

Market signals through 2026 point to CBD expanding beyond oils and gummies into food, beverage and confectionery formats — and chewing gum is one of the most visible new formats. Industry summaries and market research (ReportCubes and others) describe rapid category expansion into food & beverage and confectionery segments, driven by product reformulation and clearer regulatory guardrails. Retail data from the global confectionery and breath mints channel underscores why supermarkets matter: supermarkets were the dominant route to market, accounting for approximately 36.9% channel share and a breath mints revenue pool of roughly US$1.55bn in 2025. Those numbers explain why supermarket shelf‑space is now a strategic battleground for CBD gum.

Early commercialisation signals

• Multiple supermarket rollouts and high‑street listings reported in 2026 show test assortments of CBD gum in both ambient confectionery aisles and wellness bays.
• Challenger gum brands — already recognised for shaking up the gum category (as noted by The Grocer) — have created retailer appetite for functional variants, making CBD a natural next step.
• Trade commentators and investor write‑ups this year flag accelerating commercialisation and project a multi‑billion dollar sector as formats diversify beyond tinctures and edibles.

Why it matters

There are three linked reasons the supermarket rollouts and high‑street listings matter for the market.

1. Accessibility and mass adoption

Supermarkets and hypermarkets remain the dominant channel for confectionery and mints. When CBD gum is available where everyday shoppers browse, adoption shifts from the early adopter wellness crowd to a broader mainstream audience seeking convenience and familiarity.

2. Regulatory confidence

Regulatory clarity around hemp and THC thresholds — commonly cited at the 0.2% THC limit in many industry discussions — is giving retailers more confidence to list CBD‑infused food formats. Clear labelling, Certificates of Analysis (COAs) and supply‑chain provenance are becoming a prerequisite for listings, and retailers are responding accordingly.

3. Shopper priorities

Retail insight reports (IGD) indicate 2026 shoppers prioritise health, convenience and clear product provenance. CBD chewing gum fits that brief as a compact, micro‑doseable, ‘wellness‑on‑the‑go’ SKU that can be used discreetly during commuting, between meetings or after exercise.

Examples: adjacent formats and retail readiness

Chewing gum will not arrive in isolation: retailers are listing a range of related formats that help shoppers experiment with cannabinoid microdosing and functional confectionery.

• Breath mints and lozenges that combine convenience with measured portions are already established — for example, products such as Mr Moxeys Mints Relief and CBD Living Lozenges — Cherry demonstrate how confectionery formats can bridge familiarity and function for shoppers.
• Gummies remain a popular entry point for many consumers, with options at different pack sizes to suit trial and repeat purchases such as Wylde CBD Gummy Bears 30x (10mg) and Wylde CBD Gummy Bears 60x (10mg).
• For shoppers who favour adding CBD to drinks, compact formats such as the CBD Drinks Enhancer show how micro‑dosing product design can be incorporated into everyday rituals.

These adjacent formats demonstrate the commercial logic: once shoppers trust measured, quality‑assured formats, trying a single‑serve chewable becomes a small behavioural step rather than a leap.

Future outlook

Category disruption is underway. Challenger gum brands have already proved consumers are open to new positioning and flavour innovations; when CBD is layered into that dynamic, it changes the gum aisle from a flavour competition to a functional shelf. Expect the following developments through 2026–2027:

• Refinement of dosing conventions and clearer front‑of‑pack microdose statements to help shoppers compare SKUs quickly.
• Greater emphasis on provenance, lab testing and visible COAs to meet retailer listing criteria and shopper trust requirements.
• Expansion of vending and checkout placements as CBD gum proves resilient to impulse purchasing patterns common in confectionery.
• Investment from larger confectionery players and grocery buyers as the projected multi‑billion dollar opportunity crystallises and supply chains scale.

Conclusion

The 2026 rollouts of CBD chewing gum across UK supermarkets and high‑street retailers are an important litmus test for mainstream adoption. Thanks to clearer regulatory framing, shopper demand for convenience and the proven commercial power of supermarket channels, CBD gum is well positioned to become a recognised micro‑dose wellness format. For retailers, success will depend on rigorous quality assurance, accessible dosing cues and smart category placement; for shoppers, the appeal will be familiar, convenient access to a new way of sampling CBD alongside established formats such as mints, lozenges and gummies.

As the year progresses, watch for packaging innovations, new flavour pairings and clearer provenance cues — all of which will influence whether CBD chewing gum becomes an everyday wellness staple or remains a niche experiment on the confectionery shelf.